Developer docs
API playgroundTry for free, no card

Search company profiles

Catalia Health

Full company profile

uuid0002buq

Namestring
Catalia Health
Websiteurl
cataliahealth.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Catalia Health is a San Francisco-based, venture-backed healthcare technology company founded in 2014 that builds Mabu, a personal healthcare companion designed to support patients with chronic disease. Mabu functions as an interactive patient-facing tool that engages users in their daily care routines and simultaneously collects longitudinal patient-reported data, which the company intends to share with healthcare providers to inform care decisions.

The company's core product combines a hardware companion device with conversational and data-collection software, rooted in research from MIT Media Lab, where the project originated in 2014. Catalia has attracted design and engineering capital from IDEO and institutional venture investors, and has drawn strategic interest from pharmaceutical partners (notably Astellas Pharma in 2017), indicating a go-to-market oriented toward pharma-sponsored deployments and health-system integrations rather than direct-to-consumer sales. The Mabu product surface and the provider-facing data layer together constitute the platform the company is building.

Catalia's business model is not explicitly disclosed in the available data, but the combination of a regulated medical-device-adjacent product, pharma strategic investment, and accelerator engagement (MedTech Innovator) is consistent with enterprise contracts to payers, providers, and pharmaceutical sponsors, rather than a consumer subscription model. The company remains private, has 11-50 employees, and has raised approximately $7.75M in disclosed equity funding through late 2017, with no subsequent financing activity visible in the input data.

Short descriptiontext

Catalia Health builds Mabu, a personal healthcare companion that engages chronic disease patients in daily care and transmits collected data to healthcare providers. The San Francisco company, founded in 2014, sells into pharma-sponsored and health-system channels.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
healthcare companion robot, chronic disease management, patient engagement platform, healthcare data collection, personalized patient care
Industry3 codes
1Therapeutic Companion Apps (Drug-Device-Digital Combination)
CodeHLACANAHPrimaryYes
2Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD)
CodeHLACAGAGPrimaryNo
3Care Management & Coordination Platforms (case/disease management workflows)
CodeHLACAHADPrimaryNo
NAICS code1 code
  • Home Health Care Services621610
SIC code2 codes
  • Services-Health Services8000
  • Services-Misc Health & Allied Services, Nec8090
Product category
Digital Health
Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Catalia Health creates the Mabu personal healthcare companion designed to engage patients with chronic disease through daily interactions. The companion supports patient self-management and adherence while collecting longitudinal health data that is shared with healthcare providers such as hospitals, pharmaceutical companies, and payers.

Differentiator
Functional benefit
Problem solved
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1care.coach
TypeDirect peer
Description

care.coach provides avatar-based digital health companions that engage chronic and high-need patients 24/7 and report data to providers — closely aligned with Catalia's companion-plus-provider-data model.

2Pillo Health
TypeDirect peer
Description

Pillo Health developed a countertop companion robot for medication reminders and chronic disease support, directly comparable to Catalia's Mabu in form factor, target population, and engagement model.

3Omada Health
TypeEmerging player
Description

Omada is a leading digital chronic disease prevention and management platform serving prediabetes, diabetes, hypertension, and behavioral health. It competes with Catalia for the same payer/provider budgets, though delivered as a software-only program.

4WellDoc
TypeDirect peer
Description

WellDoc offers FDA-cleared digital therapeutic platforms for chronic disease (notably diabetes) that collect patient data and deliver personalized coaching — a directly adjacent companion-data therapeutic model.

5Ginger (Headspace Health)
TypeEmerging player
Description

Ginger delivers on-demand behavioral health coaching and therapy via a digital companion model, with data integration for health plan partners — overlapping Catalia's continuous-engagement companion approach in a different therapeutic area.

6Propeller Health (ResMed)
TypeDirect peer
Description

Propeller Health combines connected inhalers and a companion app to manage asthma and COPD, delivering patient engagement plus provider data — closely comparable to Catalia's chronic disease + provider data loop.

7Livongo (Teladoc Health)
TypeBroad incumbent
Description

Livongo, now part of Teladoc, provides condition-specific chronic disease management (diabetes, hypertension, behavioral health) with connected devices and data-driven coaching — the closest broad incumbent and the benchmark Catalia must beat on engagement.

8Virta Health
TypeEmerging player
Description

Virta Health delivers digitally-enabled type 2 diabetes reversal and chronic care, combining remote monitoring with continuous remote care — a comparable chronic-condition, data-to-provider business model.

9Medisafe
TypeEmerging player
Description

Medisafe is a medication adherence and chronic disease management platform for pharma and providers, using a digital companion to drive daily engagement — comparable to Catalia's companion-driven adherence model.

10Stanley Black & Decker (Pria)
TypeBroad incumbent
Description

Pria by Stanley Black & Decker is a home health companion robot for medication reminders and daily check-ins, making the parent company a broad incumbent comparable to Catalia in hardware-based chronic care companionship.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Catalia Health

Digital Healthcataliahealth.com

Catalia Health builds Mabu, a personal healthcare companion that engages chronic disease patients in daily care and transmits collected data to healthcare providers. The San Francisco company, founded in 2014, sells into pharma-sponsored and health-system channels.

What Catalia Health does

Catalia Health is a San Francisco-based, venture-backed healthcare technology company founded in 2014 that builds Mabu, a personal healthcare companion designed to support patients with chronic disease. Mabu functions as an interactive patient-facing tool that engages users in their daily care routines and simultaneously collects longitudinal patient-reported data, which the company intends to share with healthcare providers to inform care decisions.

The company's core product combines a hardware companion device with conversational and data-collection software, rooted in research from MIT Media Lab, where the project originated in 2014. Catalia has attracted design and engineering capital from IDEO and institutional venture investors, and has drawn strategic interest from pharmaceutical partners (notably Astellas Pharma in 2017), indicating a go-to-market oriented toward pharma-sponsored deployments and health-system integrations rather than direct-to-consumer sales. The Mabu product surface and the provider-facing data layer together constitute the platform the company is building.

Catalia's business model is not explicitly disclosed in the available data, but the combination of a regulated medical-device-adjacent product, pharma strategic investment, and accelerator engagement (MedTech Innovator) is consistent with enterprise contracts to payers, providers, and pharmaceutical sponsors, rather than a consumer subscription model. The company remains private, has 11-50 employees, and has raised approximately $7.75M in disclosed equity funding through late 2017, with no subsequent financing activity visible in the input data.

Catalia Health firmographics

Firmographics
Name
Catalia Health
Website
https://cataliahealth.com
Company type
Private
Founded year
2014
Headcount range
11–50 employees
Short description
Catalia Health builds Mabu, a personal healthcare companion that engages chronic disease patients in daily care and transmits collected data to healthcare providers. The San Francisco company, founded in 2014, sells into pharma-sponsored and health-system channels.
Ownership category
akta.pro rank

Catalia Health industry classification

Industry
Product category
Digital Health
NAICS
Home Health Care Services (621610)
SIC
Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH)
akta.pro secondary industries
Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD) (HLACAGAG), Care Management & Coordination Platforms (case/disease management workflows) (HLACAHAD)

Keywords

  • Healthcare companion robot
  • Chronic disease management
  • Patient engagement platform
  • Healthcare data collection
  • Personalized patient care

Where Catalia Health is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Catalia Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Catalia Health product offering

Product offering

Core offering

Catalia Health creates the Mabu personal healthcare companion designed to engage patients with chronic disease through daily interactions. The companion supports patient self-management and adherence while collecting longitudinal health data that is shared with healthcare providers such as hospitals, pharmaceutical companies, and payers.

Differentiator

Problem solved

Functional benefit

Companies that use Catalia Health

Customer profile

Ideal customer profiles2 records

Catalia Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Catalia Health partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

Catalia Health competitors and assessment

Company assessment

Direct peers

  • care.coach: care.coach provides avatar-based digital health companions that engage chronic and high-need patients 24/7 and report data to providers — closely aligned with Catalia's companion-plus-provider-data model.
  • Pillo Health: Pillo Health developed a countertop companion robot for medication reminders and chronic disease support, directly comparable to Catalia's Mabu in form factor, target population, and engagement model.
  • WellDoc: WellDoc offers FDA-cleared digital therapeutic platforms for chronic disease (notably diabetes) that collect patient data and deliver personalized coaching — a directly adjacent companion-data therapeutic model.
  • Propeller Health (ResMed): Propeller Health combines connected inhalers and a companion app to manage asthma and COPD, delivering patient engagement plus provider data — closely comparable to Catalia's chronic disease + provider data loop.

Emerging players

  • Omada Health: Omada is a leading digital chronic disease prevention and management platform serving prediabetes, diabetes, hypertension, and behavioral health. It competes with Catalia for the same payer/provider budgets, though delivered as a software-only program.
  • Ginger (Headspace Health): Ginger delivers on-demand behavioral health coaching and therapy via a digital companion model, with data integration for health plan partners — overlapping Catalia's continuous-engagement companion approach in a different therapeutic area.
  • Virta Health: Virta Health delivers digitally-enabled type 2 diabetes reversal and chronic care, combining remote monitoring with continuous remote care — a comparable chronic-condition, data-to-provider business model.
  • Medisafe: Medisafe is a medication adherence and chronic disease management platform for pharma and providers, using a digital companion to drive daily engagement — comparable to Catalia's companion-driven adherence model.

Broad incumbents

  • Livongo (Teladoc Health): Livongo, now part of Teladoc, provides condition-specific chronic disease management (diabetes, hypertension, behavioral health) with connected devices and data-driven coaching — the closest broad incumbent and the benchmark Catalia must beat on engagement.
  • Stanley Black & Decker (Pria): Pria by Stanley Black & Decker is a home health companion robot for medication reminders and daily check-ins, making the parent company a broad incumbent comparable to Catalia in hardware-based chronic care companionship.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights5 records

Customer concentration

Catalia Health social profiles

Digital presence

Catalia Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Catalia Health leadership team

Management profile

Number of profiles

Catalia Health funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Catalia Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Catalia Health

What does Catalia Health do?

Catalia Health creates the Mabu personal healthcare companion designed to engage patients with chronic disease through daily interactions. The companion supports patient self-management and adherence while collecting longitudinal health data that is shared with healthcare providers such as hospitals, pharmaceutical companies, and payers.

When was Catalia Health founded?

Catalia Health was founded in 2014. It employs 11 to 50 people.

Where is Catalia Health based?

Catalia Health is headquartered in San Francisco, United States, in the North America region.

Who are Catalia Health's main competitors?

Direct peers on record are care.coach, Pillo Health, WellDoc and Propeller Health (ResMed). Emerging players are Omada Health, Ginger (Headspace Health), Virta Health and Medisafe. Broad incumbents are Livongo (Teladoc Health) and Stanley Black & Decker (Pria).

Does Catalia Health have an API?

No public API is recorded for Catalia Health.

What industry is Catalia Health in?

Catalia Health's product category is Digital Health. Its primary akta.pro industry code is HLACANAH, Therapeutic Companion Apps (Drug-Device-Digital Combination), with a secondary code of HLACAGAG, Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD). Its NAICS code is 621610 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical Device and Diagnostic industryCatalia HealthCatalia Health, a medical solutions company based in San Francisco, has launched the Mabu Healthcare Coach platform that integrates human psychology with artificial intelligence to enhance patient care. The platform is designed to learn about patients over time, providing real-time updates on their health and managing treatment with personalized data. This innovative approach aims to significantly improve the way healthcare is delivered by serving as a personal healthcare companion.PR NewswireTransPerfect DataForce Selected by Catalia Health to Add Spanish-Language Capabilities to Its Personal Healthcare Companion, MabuTransPerfect DataForce has been selected by Catalia Health to add Spanish-language capabilities to Mabu, the AI-powered robotic wellness coach used for patient engagement and chronic disease management. The Spanish version of Mabu is being launched to support a patient-reported outcome project for a major pharmaceutical client. The expansion will enable Catalia Health to reach a significantly larger patient population and improve health outcomes for Spanish-speaking patients.PCMagMabu the Pint-Sized Robot Wants to Manage Your HealthCatalia Health is commercially rolling out Mabu, a home-based social robot designed to assist patients with chronic disease management through daily AI-driven conversations and health monitoring. The company has secured pilots with major healthcare providers like Kaiser Permanente and pharmaceutical manufacturers in oncology and immunology fields, supported by $7.8 million in funding.ITIJCatalia Health working with American Heart Association on healthcare solutionsCatalia Health has partnered with the American Heart Association's Center for Health Technology & Innovation to create scalable healthcare solutions. This collaboration aims to enhance patient care for those suffering from heart-related ailments through Catalia’s AI-powered patient engagement platform, Mabu. The partnership is a significant step toward improving patient outcomes and expanding healthcare capabilities.VentureBeatMabu the robot helps congestive heart failure patients monitor symptomsCatalia Health reports that users of Mabu, a conversational AI robot for congestive heart failure patients, are 84% more likely to monitor their symptoms based on initial feedback from 40 Kaiser Permanente patients. The company is expanding its robotic health solutions to include oncology and immunology care while developing features to replace routine professional check-ins. Future developments include new insurance partnerships and potential facial recognition integration to personalize patient interactions.TimeMachines Treating Patients? It’s Already HappeningThe article examines the evolving role of artificial intelligence in healthcare, highlighting Mabu, a robot developed by Catalia Health that assists patients with chronic conditions through daily monitoring. It contrasts this targeted application with the mixed historical performance of IBM Watson for Oncology, which faced criticism for data integration issues and biased recommendations despite its initial promise. Experts emphasize that while AI excels at analyzing medical images and data patterns to support diagnosis, it is best used as a tool to augment human clinicians rather than replace them.Fast CompanyThis little robot helps care for people with chronic conditionsMabu, a robot developed by the startup Catalia Health, interacts with patients to help them manage their health and medication, recently starting its role with heart failure patients under Kaiser Permanente. The robot also aims to assist rheumatoid arthritis and late-stage kidney cancer patients with backing from pharmaceutical companies. Designed to enhance patient care, Mabu gathers health information through conversation and adapts its interaction based on individual patient needs.Stanford University School of EngineeringInsights from Embodied and Non-embodied AI PanelThe article covers a panel discussion on embodied and non-embodied AI featuring experts from Stanford University, Hanson Robotics, Catalia Health, and AvatarMind. The panelists explore topics including AI's psychological effects, cultural considerations, emotional responses, healthcare applications, and societal integration of robots.PR NewswireCatalia Health Announces Dr. Pat Basu As Newest Board MemberCatalia Health announced the appointment of Dr. Pat Basu as its newest board member. Basu brings over 15 years of experience spanning corporate, government, private equity, and clinical sectors, having previously served as a White House advisor under the Obama administration and co-founded Doctor on Demand. He currently serves as a partner at Chicago Pacific Founders and most recently held a senior vice president role at Optum/UnitedHealth Group, where he managed a nine billion dollar profit and loss statement.PR NewswireCatalia Health joins American Heart Association's Center for Health Technology & Innovation Innovators NetworkCatalia Health has joined the American Heart Association's Center for Health Technology & Innovation's Innovators Network to develop innovative healthcare solutions. Their collaboration aims to enhance patient engagement through Catalia Health's AI-powered platform, which supports patients managing chronic conditions, particularly heart-related ailments. This partnership emphasizes the importance of addressing healthcare challenges and improving patient outcomes.